Alterity Completes Neurogenerative Disease Trial

MT NewswiresMar 26 21:37 ET

Alterity Therapeutics Raises About AU$2.1 Million Via US Facility; Shares Soar 17%

MT NewswiresFeb 2 19:36 ET

Alterity Therapeutics (ASX:ATH) Shareholder Returns Have Been Stellar, Earning 260% in 1 Year

Yahoo FinanceJan 30 16:58 ET

ADRs Advance; Alterity Therapeutics Ltd. Climbs 57%

Dow JonesJan 30 16:30 ET

Alterity Reports Positive Phase Two Trial Results for Multiple System Atrophy Drug Candidate, Shares Surge 125% to Record High

MT NewswiresJan 29 22:10 ET

Alterity Therapeutics Ltd: ATH shareholder newsletter January 2025

ASXJan 16 22:43 ET · Announcements